Distinct mechanisms regulate TIMP-1 expression at different stages of phorbol ester-mediated differentiation of U937 cells

被引:13
作者
Doyle, GAR
SaarialhoKere, UK
Parks, WC
机构
[1] WASHINGTON UNIV, SCH MED, DEPT MED DERMATOL, ST LOUIS, MO 63110 USA
[2] WASHINGTON UNIV, SCH MED, DEPT CELL BIOL & PHYSIOL, ST LOUIS, MO 63110 USA
关键词
D O I
10.1021/bi962161e
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Upon exposure to 12-O-tetradecanoylphorbol 13-acetate (PMA), promonocyte-like U937 cells differentiate into macrophage-like cells and begin to express certain metalloproteinases and TIMP-1. We report here that distinct mechanisms regulate TIMP-1 production in PMA-treated U937 cells. TIMP-1 protein and steady-state mRNA levels increased about 10-fold in PMA-differentiated cells compared to undifferentiated cells. TIMP-1 transcription increased about 2.5-fold, but this stimulation was not detected until at least 48 h post-PMA. In contrast, the half-life for TIMP-1 mRNA increased about 3-fold and was detected at 8 h post-PMA. Using in vitro translation assays, we found that TIMP-1 mRNA from PMA-differentiated cells translated about 5-fold less efficiently than that from basal cells, suggesting structural differences in TIMP-1 mRNA in basal and differentiated U937 cells. Although primer extension and RNase protection analyses showed 5' heterogeneity of TIMP-1 transcripts, all forms were equally stimulated in response to PMA-mediated differentiation. The poly(A) tail length of TIMP-1 mRNA, however, was longer in PMA-treated cells. Our findings suggested that up-regulation of TIMP-1 expression in PMA-treated U937 cells is mediated early by enhanced TIMP-1 mRNA stability, possibly related to increased poly(A) tail length, and later by an increase in transcription rate.
引用
收藏
页码:2492 / 2500
页数:9
相关论文
共 53 条
[1]  
ALITALO R, 1990, BLOOD, V75, P1974
[2]  
AVALOS BR, 1988, BLOOD, V71, P1720
[3]  
BANDA MJ, 1995, WOUNDS, V7, pA45
[4]  
BOORSTEIN WR, 1989, METHOD ENZYMOL, V180, P347
[5]   POLYAMINE INVOLVEMENT IN THE CELL-CYCLE, APOPTOSIS, AND AUTOIMMUNITY [J].
BROOKS, WH .
MEDICAL HYPOTHESES, 1995, 44 (05) :331-338
[6]   TISSUE INHIBITOR OF METALLOPROTEINASES-1 IS DECREASES AND ACTIVATED GELATINASES ARE INCREASED IN CHRONIC WOUNDS [J].
BULLEN, EC ;
LONGAKER, MT ;
UPDIKE, DL ;
BENTON, R ;
LADIN, D ;
HOU, ZZ ;
HOWARD, EW .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1995, 104 (02) :236-240
[7]  
CAMPBELL CE, 1991, J BIOL CHEM, V266, P7199
[8]  
CAMPBELL EJ, 1991, J IMMUNOL, V146, P1286
[9]   PRIMARY STRUCTURE AND CDNA CLONING OF HUMAN FIBROBLAST COLLAGENASE INHIBITOR [J].
CARMICHAEL, DF ;
SOMMER, A ;
THOMPSON, RC ;
ANDERSON, DC ;
SMITH, CG ;
WELGUS, HG ;
STRICKLIN, GP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (08) :2407-2411
[10]   REGULATION OF THE EXPRESSION OF TISSUE INHIBITOR OF METALLOPROTEINASES AND COLLAGENASE BY RETINOIDS AND GLUCOCORTICOIDS IN HUMAN-FIBROBLASTS [J].
CLARK, SD ;
KOBAYASHI, DK ;
WELGUS, HG .
JOURNAL OF CLINICAL INVESTIGATION, 1987, 80 (05) :1280-1288